BTIG Virtual Biotechnology Conference 2023: Context CEOMartin Lehr will participate in a fireside chat taking place onMonday, August 7, 2023 , at10:30 a.m. ET . Context will also participate in one-on-one meetings. To register for this conference, please click here.H.C. Wainwright Immune Cell Engager Virtual Conference : Context CEOMartin Lehr will participate in a fireside chat taking placeThursday, August 17, 2023 , at11:30 a.m. ET . Context will also participate in one-on-one meetings. For additional details regarding this one-day conference, please click here.
About
Forward-looking Statements
This press release contains “forward-looking statements” that involve substantial risks and uncertainties for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. Any statements, other than statements of historical fact, included in this press release regarding strategy, future operations, prospects, plans and objectives of management, including words such as “may,” “will,” “expect,” “anticipate,” “plan,” “intend,” and similar expressions (as well as other words or expressions referencing future events, conditions, or circumstances) are forward-looking statements. These include, without limitation, statements regarding (i) the ability of the Company and its employees to participate in and present at conferences, (ii) the potential benefits, characteristics, and side effect profile of our product candidate, (iii) the likelihood data will support future development, and (iv) the likelihood of obtaining regulatory approval of our product candidate. Forward-looking statements in this release involve substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by the forward-looking statements, and we therefore cannot assure you that our plans, intentions, expectations, or strategies will be attained or achieved. Other factors that may cause actual results to differ from those expressed or implied in the forward-looking statements in this press release are discussed in our filings with the U.S. Securities and Exchange Commission, including the section titled “Risk Factors” contained therein. Except as otherwise required by law, we disclaim any intention or obligation to update or revise any forward-looking statements, which speak only as of the date they were made, whether as a result of new information, future events, or circumstances or otherwise.
Media Contact:
6 Degrees
917-797-7904
gcestari@6degreespr.com
Investor Relations Contact:
IR@contexttherapeutics.com
Source:
2023 GlobeNewswire, Inc., source